Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
ribosome inactivating protein/rak
Povezava se shrani v odložišče
15 rezultatov
Production and uses of type I ribosome inactivating proteins
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present disclosure generally relates to the production and/or therapeutic use of recombinant type 1 ribosome inhibiting proteins for the treatment of cancer and infectious diseases.
2. Description of the Relevant Art
Ribosome Inactivating
Analogs of ribosome-inactivating proteins
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
The present invention relates, in general, to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to analogs of ribosome-inactivating proteins specifically modified for conjugation to targeting molecules and to polynucleotides encoding
Immunotoxins comprising ribosome-inactivating proteins
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention generally relates to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to ribosome-inactivating proteins, to analogs of ribosome-inactivating proteins, to polynucleotides encoding such proteins and
Immunotoxins comprising ribosome-inactivating proteins
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention generally relates to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to ribosome-inactivating proteins, to analogs of ribosome-inactivating proteins, to polynucleotides encoding such proteins and
Immunotoxins comprising ribosome-inactivating proteins
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention generally relates to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to ribosome-inactivating proteins, to analogs of ribosome-inactivating proteins, to polynucleotides encoding such proteins and
Immunotoxins comprising ribosome-inactivating proteins
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention generally relates to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to ribosome-inactivating proteins, to analogs of ribosome-inactivating proteins, to polynucleotides encoding such proteins and
Immunotoxins comprising ribosome-inactivating proteins
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention generally relates to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to ribosome-inactivating proteins, to analogs of ribosome-inactivating proteins, to polynucleotides encoding such proteins and
Materials comprising and methods of preparation and use for ribosome-inactivating proteins
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
The present invention relates, in general, to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to polynucleotides encoding ribosome-inactivating proteins, to polynucleotides encoding analogs of ribosome-inactivating proteins
Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention relates to the isolation and characterization of a novel ribosome-inactivating protein from the plant Bryonia dioica. The oligonucleotide sequence encoding the protein and its amino acid sequence have been determined. The invention also relates to
Type-1 ribosome-inactivating protein
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The invention discloses a new type-1 ribosome-inactivating protein (RIP), referred to as bouganin, isolated from the leaves of Bougainvillea species, especially B. spectabilis Willd. Bouganin differs from other type-1 RIP by its unique amino acid composition. Bouganin has a
Type-1 ribosome-inactivating protein
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The invention discloses a new type-1 ribosome-inactivating protein (RIP), referred to as bouganin, isolated from the leaves of Bougainvillea species, especially B. spectabilis Willd. Bouganin differs from other type-1 RIP by its unique amino acid composition. Bouganin has a
Treatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugates
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
This invention relates to the use of particular conjugates which are targeted to inhibit cell proliferation, and more specifically, to the use of fibroblast growth factor conjugated to a cytotoxic agent.
BACKGROUND OF THE INVENTION
Angiogenesis plays a critical role in embryonic development and in
Polynucleotides encoding gelonin sequences
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The present invention generally relates to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to ribosome-inactivating proteins, to analogs of ribosome-inactivating proteins, to polynucleotides encoding such proteins and analogs, some of which
Fusion proteins and polynucleotides encoding gelonin sequences
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention generally relates to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to ribosome-inactivating proteins, to analogs of ribosome-inactivating proteins, to polynucleotides encoding such proteins and
Mutant trichosanthin
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
This application claims priority under 35 U.S.C. .sctn.119(a) (d) to Chinese patent application serial number 00119553.0, filed on Aug. 2, 2000 and Chinese patent application serial number 001103102.6, filed on Jan. 18, 2001.
FIELD OF THE INVENTION
This invention relates to mutant trichosanthin
Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo
- Deluje v 55 jezikih
- Zeliščna zdravila, podprta z znanostjo
- Prepoznavanje zelišč po sliki
- Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
- Preberite znanstvene publikacije, povezane z vašim iskanjem
- Iščite zdravilna zelišča po njihovih učinkih
- Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti
Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah
